BMB Reports

생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biology)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine

  • Mu, Nan (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Liu, Nannan (Experiment Teaching Center of Basic Medicine, The Fourth Military Medical University) ;
  • Hao, Qiang (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Xu, Yujin (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Li, Jialin (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Li, Weina (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Wu, Shouzhen (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Zhang, Cun (State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy) ;
  • Su, Haichuan (Department of Oncology, Tangdu Hospital, Fourth Military Medical University)
  • 투고 : 2013.07.22
  • 심사 : 2013.11.13
  • 발행 : 2014.07.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

B7-H4 is a member of B7 family of co-inhibitory molecules and B7-H4 protein is found to be overexpressed in many human cancers and which is usually associated with poor survival. In this study, we developed a therapeutic vaccine made from a fusion protein composed of a tetanus toxoid (TT) T-helper cell epitope and human B7-H4IgV domain (TT-rhB7-H4IgV). We investigated the anti-tumor effect of the TT-rhB7-H4IgV vaccine in BALB/c mice and SP2/0 myeloma growth was significantly suppressed in mice. The TT-rhB7-H4IgV vaccine induced high-titer specific antibodies in mice. Further, the antibodies induced by TT-rhB7-H4IgV vaccine were capable of depleting SP2/0 cells through complement-dependent cytotoxicity (CDC) in vitro. On the other hand, the poor cellular immune response was irrelevant to the therapeutic efficacy. These results indicate that the recombinant TT-rhB7-H4IgV vaccine might be a useful candidate of immunotherapy for the treatment of some tumors associated with abnormal expression of B7-H4.

키워드

참고문헌

  1. Prasad, D. V., Richards, S., Mai, X. M. and Dong, C. (2003) B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18, 863-873. https://doi.org/10.1016/S1074-7613(03)00147-X
  2. Choi, I. H., Zhu, G., Sica, G. L., Strome, S. E., Cheville, J. C., Lau, J. S., Zhu, Y., Flies, D. B., Tamada, K. and Chen, L. (2003) Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J. Immunol. 171, 4650-4654. https://doi.org/10.4049/jimmunol.171.9.4650
  3. Sica, G. L., Choi, I. H., Zhu, G., Tamada, K., Wang, S. D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J. and Chen, L. (2003) B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18, 849-861. https://doi.org/10.1016/S1074-7613(03)00152-3
  4. Salceda, S., Tang, T., Kmet, M., Munteanu, A., Ghosh, M., Macina, R., Liu, W., Pilkington, G. and Papkoff, J. (2005) The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp. Cell Res. 306, 128-141. https://doi.org/10.1016/j.yexcr.2005.01.018
  5. Krambeck, A. E., Thompson, R. H., Dong, H., Lohse, C. M., Park, E. S., Kuntz, S. M., Leibovich, B. C., Blute, M. L., Cheville, J. C. and Kwon, E. D. (2006) B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc. Natl. Acad. Sci. U.S.A. 103, 10391-10396. https://doi.org/10.1073/pnas.0600937103
  6. Fauci, J. M., Straughn, J. M., Jr., Ferrone, S. and Buchsbaum, D. J. (2012) A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer. Gynecol. Oncol. 127, 420-425. https://doi.org/10.1016/j.ygyno.2012.08.017
  7. Simon, I., Katsaros, D., Rigault de la Longrais, I., Massobrio, M., Scorilas, A., Kim, N. W., Sarno, M. J., Wolfert, R. L. and Diamandis, E. P. (2007) B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression. Gynecol. Oncol. 106, 334-341. https://doi.org/10.1016/j.ygyno.2007.03.035
  8. Quandt, D., Fiedler, E., Boettcher, D., Marsch, W. and Seliger, B. (2011) B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response. Clin. Cancer Res. 17, 3100-3111. https://doi.org/10.1158/1078-0432.CCR-10-2268
  9. Chen, L. J., Sun, J., Wu, H. Y., Zhou, S. M., Tan, Y., Tan, M., Shan, B. E., Lu, B. F. and Zhang, X. G. (2011) B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol. Immunother. 60, 1047-1055. https://doi.org/10.1007/s00262-011-1017-3
  10. Sun, S. Q., Jiang, C. G., Lin, Y., Jin, Y. L. and Huang, P. L. (2012) Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines. J. Int. Med. Res. 40, 497-506. https://doi.org/10.1177/147323001204000211
  11. Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., Lackner, A., Alvarez, X., Ochoa, A., Chen, L. and Zou, W. (2006) B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203, 871-881. https://doi.org/10.1084/jem.20050930
  12. Dalum, I., Butler, D. M., Jensen, M. R., Hindersson, P., Steinaa, L., Waterston, A. M., Grell, S. N., Feldmann, M., Elsner, H. I. and Mouritsen, S. (1999) Therapeutic antibodies elicited by immunization against TNF-alpha. Nat. Biotechnol. 17, 666-669. https://doi.org/10.1038/10878
  13. Dalum, I., Jensen, M. R., Gregorius, K., Thomasen, C. M., Elsner, H. I. and Mouritsen, S. (1997) Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope. Mol. Immunol. 34, 1113-1120. https://doi.org/10.1016/S0161-5890(97)00147-8
  14. Valmori, D., Pessi, A., Bianchi, E. and Corradin, G. (1992) Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. 149, 717-721.
  15. Yu, Z., Healy, F., Valmori, D., Escobar, P., Corradin, G. and Mach, J. P. (1994) Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells. Int. J. Cancer 56, 244-248. https://doi.org/10.1002/ijc.2910560217
  16. Zhang, C., Wang, W., Qin, X., Xu, Y., Huang, T., Hao, Q., Li, W., Wu, S. and Zhang, Y. (2013) B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice. Oncol. Rep. 30, 2442-2448. https://doi.org/10.3892/or.2013.2686
  17. Suh, W. K., Wang, S., Duncan, G. S., Miyazaki, Y., Cates, E., Walker, T., Gajewska, B. U., Deenick, E., Dawicki, W., Okada, H., Wakeham, A., Itie, A., Watts, T. H., Ohashi, P. S., Jordana, M., Yoshida, H. and Mak, T. W. (2006) Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol. Cell Biol. 26, 6403-6411. https://doi.org/10.1128/MCB.00755-06
  18. Hansen, J. D., Du Pasquier, L., Lefranc, M. P., Lopez, V., Benmansour, A. and Boudinot, P. (2009) The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective. Mol. Immunol. 46, 457-472. https://doi.org/10.1016/j.molimm.2008.10.007
  19. Zhang, C., Wu, S., Xue, X., Li, M., Qin, X., Li, W., Han, W. and Zhang, Y. (2008) Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV. Cytotherapy 10, 711-719. https://doi.org/10.1080/14653240802320237
  20. Kryczek, I., Wei, S., Zhu, G., Myers, L., Mottram, P., Cheng, P., Chen, L., Coukos, G. and Zou, W. (2007) Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res. 67, 8900-8905. https://doi.org/10.1158/0008-5472.CAN-07-1866
  21. Lin, C. C., Chou, C. W., Shiau, A. L., Tu, C. F., Ko, T. M., Chen, Y. L., Yang, B. C., Tao, M. H. and Lai, M. D. (2004) Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu. Mol. Ther. 10, 290-301. https://doi.org/10.1016/j.ymthe.2004.05.015
  22. Renard, V., Sonderbye, L., Ebbehoj, K., Rasmussen, P. B., Gregorius, K., Gottschalk, T., Mouritsen, S., Gautam, A. and Leach, D. R. (2003) HER-2 DNA and protein vaccines containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER-2 transgenic mice. J. Immunol. 171, 1588-1595. https://doi.org/10.4049/jimmunol.171.3.1588

피인용 문헌

  1. Immunosuppressive Effect of B7-H4 Pathway in a Murine Systemic Lupus Erythematosus Model vol.8, pp.1664-3224, 2017, https://doi.org/10.3389/fimmu.2017.01765
  2. Construction, expression and functional analysis of anti-B7-H4-scFv-CH3 recombinant antibody vol.43, pp.4, 2018, https://doi.org/10.1007/s12038-018-9772-3